¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"free radical formation toxicity"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
¿µ¹® radical mastectomy ÇÑ±Û ±ÙÄ¡À¯¹æÀýÁ¦¼ú
¼³¸í   
  À¯¹æ¾Ï¿¡ °É·ÈÀ» ¶§ À¯¹æÀ» ÀýÁ¦Çϴ ¼ö¼ú¹æ¹ýÀ¸·Î, ¾Ï¿¡ ÀÌȯµÈ À¯¹æ°ú Å«°¡½¿(pectoralis major), ÀÛÀº°¡½¿±Ù(pectoralis minor)°ú °Üµå¶û ¸²ÇÁÀý µîÀ» ¸ðµÎ ÀýÁ¦Çϴ ¹æ¹ýÀÌ´Ù. ÀÌ ¹æ¹ýÀ» »ç¿ëÇϸé, Ä¡·áÈ¿°ú¿¡ ºñÇØ ³Ê¹« Áö³ªÄ£ È¯ÀÚÀÇ ¼ö¼úÈÄ ÇÕº´ÁõÀ» °¡Á®¿À°Ô µÇ¹Ç·Î ¿äÁòÀº Áß¿ä½Å°æ°ú ÀÛÀº°¡½¿±ÙÀ» »ì¸®´Â º¯Çü±ÙÄ¡À¯¹æÀýÁ¦¼ú(modified radical mastectomy)¸¦ ÁַΠ½ÃÇàÇÑ´Ù.
¿µ¹® toxicity ÇÑ±Û µ¶¼º
¼³¸í   
  »ýü¿¡ À־ٶ÷Á÷ÇÏÁö ¾ÊÀº ¾à¹° ÀÛ¿ëÀ» ¸»ÇÑ´Ù. ¾à¹°À» °ú·®À¸·Î »ç¿ëÇϸé Áßµ¶À» ÀÏÀ¸Å°¸ç, ½ÉÇÑ °æ¿ì¿¡´Â Á×À½¿¡ À̸£´Âµ¥ À̴ ¾à¹°ÀÇ ±Þ¼º µ¶¼ºÀÌ´Ù. ¸¸¼º µ¶¼ºÀº ¼Ò·®À» Àå±â°£ ¹Ýº¹ ¼·ÃëÇÏ¿´À» ¶§ÀÇ µ¶¼ºÀÌ´Ù. °£, ÄáÆÏ µî ¿©·¯ Àå±â¿Í Á¶Á÷¿¡ ´ëÇÑ µ¶¼º ¿Ü¿¡, ±âÇüÀ¯¹ß¼º, ¹ß¾Ï¼º µîµµ ¾à¹°µ¶¼ºÀÌ´Ù. ¾à¹°µ¶¼ºÀÇ °­¾àÀº ±Þ¼º µ¶¼º°Ë»ç(LD50), ¸¸¼º µ¶¼º°Ë»ç, ±âÇüÀ¯¹ß°Ë»ç, ¹ß¾Ï°Ë»ç, ¹ø½Ä°Ë»ç ±âŸ ¿©·¯ µ¿¹°°Ë»ç¿¡ ÀÇÇØ ÆÇÁ¤µÈ´Ù.
¿µ¹® reaction formation ÇÑ±Û ¹Ýµ¿Çü¼º, ¹ÝÀÀÇü¼º
¼³¸í   
  ¾ï¾Ðº¸´Ù ´õ Àû±ØÀûÀΠ¹æ¾î¸ÞÄ¿´ÏÁòÀ̸ç, ¹«ÀǽÄÀûÀΠ»ý°¢, ¼Ò¿ø, Ã浿ÀÌ ³Ê¹«³ªµµ ¹Þ¾Æµé¿©Áú ¼ö ¾ø´Â °ÍÀÏ °æ¿ì¿¡ À̿ʹ Á¤¹Ý´ë ¹æÇâÀÇ °ÍÀ» °­Á¶ÇÔÀ¸·Î½á ±×·± ¹«ÀǽÄÀûÀΠ°ÍµéÀÌ ÀǽĵÇÁö ¾Ê°Ô Çϴ °úÁ¤. ¿¹¸¦ µé¸é °¡Àå °¡ÇÐÀûÀΠ¼º°ÝÀÇ »ç¶÷ÀÌ »ýÃ¼ÇØºÎ ¹Ý´ë·ÐÀÚ°¡ µÇ´Â °æ¿ì¸¦ µé ¼ö ÀÖ´Ù. À̰ÍÀº ¶Ç °¡½¿ ±íÀÌ Àá°ÜÀִ µÎ·Á¿òÀÌ ÀǽĵǴ °ÍÀ» ÇÇÇϱâ À§Çؼ­ µÎ·Á¿òÀÇ ´ë»óÀÌ µÇ´Â Çൿ¿¡ °ñ¸ôÇϴ °æ¿ìµµ Æ÷ÇÔÀÌ µÈ´Ù. ¿¹¸¦ µé¸é, ³²ÀÚ¿¡°Ô »óó¹ÞÁö ¾ÊÀ»±î Çϴ µÎ·Á¿ò¿¡ °¡µæ Âù ¼Ò³à°¡ ÀÌ °°Àº µÎ·Á¿òÀ» ºÎÁ¤ÇÏ·Á´Â ¼ö´ÜÀ¸·Î ³­ÀâÇÑ ¼ºÇàÀ§¿¡ °ñ¸ôÇϴ °æ¿ì°¡ ÀÖ´Ù. ¶Ç ÀüóÀÇ Àڳฦ ¹Ì¿öÇϴ °è¸ð°¡ ¿ÀÈ÷·Á Áö³ªÄ¥ Á¤µµ·Î ±× ¾ÆÀ̸¦ ±Í¿©¿öÇϴ ÀÏ µûÀ§ÀÌ´Ù. 
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • oxygen toxicity
    »ê¼Òµ¶¼º
  • free radical
    ÀÚÀ¯¶óµðÄ®, ÀÚÀ¯±â
  • oxidative free radical
    »êÈ­ÀÚÀ¯±â, »êÈ­ÀÚÀ¯¶óµðÄ®
  • aqueous formation
    ¹æ¼öÇü¼º
  • adipocere formation
    ½Ã¶øÇü¼º
  • compromise formation
    ÀýÃæÇü¼º
  • concept formation
    °³³äÇü¼º
  • cystic formation
    ³¶Çü¼º
  • formation
    1. Çü¼º 2. Çüü, ü
  • rouleau formation
    ¿¬Àü»óÇü¼º
  • reaction formation
    ¹ÝÀÀÇü¼º, ¹Ýµ¿Çü¼º
  • reticular formation
    ±×¹°Ã¼, ¸Á»óü
  • rosette formation
    ·ÎÁ¦Æ®Çü¼º
  • acid radical
    »ê±â, »ê¶óµðÄ®
  • extended radical operation
    È®´ë±ÙÄ¡¼ö¼ú
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • toxicity
    µ¶¼º
  • free water clearance
    À¯¸®¼öºÐÁ¦°Å, À¯¸®¼öºÐÁ¦°ÅÀ²
  • free
    ÀÚÀ¯-, À¯¸®-
  • formation
    Çü¼º, Çüü
  • reaction formation
    ¹Ýµ¿Çü¼º, ¹ÝÀÀÇü¼º
  • radical cure
    ±ÙÄ¡, ±Ùº»Ä¡·á
  • radical excision
    ±ÙÄ¡ÀýÁ¦
  • extended radical total gastrectomy
    È®´ë±ÙÄ¡ÀüüÀ§ÀýÁ¦¼ú
  • radical subtotal gastrectomy
    ±ÙÄ¡´ëºÎºÐÀ§ÀýÁ¦¼ú
  • radical total gastrectomy
    ±ÙÄ¡ÀüüÀ§ÀýÁ¦¼ú
  • radical hysterectomy
    ±ÙÄ¡ÀÚ±ÃÀýÁ¦¼ú
  • radical operation
    ±ÙÄ¡¼ö¼ú
  • radical
    ±ÙÄ¡-
  • acid radical
    »ê±â
  • radical treatment
    ±Ùġġ·á, ±Ùº»Ä¡·á
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • free radical formation toxicity
    ÀÚÀ¯·¡µðÄ®Çü¼ºµ¶¼º
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • free radical
    ÀÚÀ¯¶óµðÄ®, ÀÚÀ¯±â
  • oxidative free radical
    »êÈ­ÀÚÀ¯±â
  • selective toxicity
    ¼±ÅÃÀûµ¶¼º
  • toxicity
    µ¶¼º
  • adipocere formation
    ½Ã¶øÇü¼º
  • aqueous formation
    ¹æ¼öÇü¼º
  • compromise formation
    ÀýÃæÇü¼º
  • concept formation
    °³³äÇü¼º
  • cystic formation
    ³¶Çü¼º
  • formation
    Çü¼º, Çüü
  • reaction formation
    ¹Ýµ¿Çü¼º, ¹ÝÀÀÇü¼º
  • reticular formation
    ±×¹°Ã¼
  • rosette formation
    ·ÎÁ¦Æ®Çü¼º
  • rouleau formation
    ¿°ÁÖÇü¼º
  • acid radical
    »ê¼º±â, »ê±â
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • free radical formation
    ÀÚÀ¯ ·¡µðÄ® Çü¼º
  • free radical formation,irradation injury
    ÀÚÀ¯ ·¡µðÄ® Çü¼º, ¹æ»ç¼± ¼Õ»ó(Û¯ÞÒàÊ áßß¿)
  • free radical formation,lipid peroxidation
    ÀÚÀ¯ ·¡µðÄ® Çü¼º, ÁöÁú °ú»êÈ­(ò·òõ Φ߫ûù)
  • aging,free radical theory
    À¯¸®±â ¼³(ë´×îÐñàã)
  • free radical
    ÀÚÀ¯¶óµðÄ®, À¯¸®±â, ÀÚÀ¯±â.
  • free radical
    ÀÚÀ¯(í»ë¦) ·¡µðÄ®
  • acetaldehyder toxicity
    ¾Æ¼¼Æ®¾Ëµ¥È÷µå µ¶¼º(¡­Ô¸àõ)
  • acetaminophen toxicity
    ¾Æ¼¼Æ®¾Æ¹Ì³ëÆæ µ¶¼º(¡­Ô¸àõ)
  • acute toxicity
    ±Þ¼º Áßµ¶, ±Þ¼º µ¶¼º(¡­Ô¸àõ).
  • anesthetic toxicity
    ¸¶ÃëÁ¦µ¶¼º.
  • halothane, toxicity
    ÇÒ·Îź µ¶¼º
  • adipocere formation
    ½Ã¶ø Çü¼º
  • ammonia formation
    ¾Ï¸ð´Ï¾ÆÇü¼º
  • antibody formation
    Ç×üÇü¼º(ù÷ô÷û¡à÷).
  • aqueous formation
    (¾È)¹æ¼öÇü¼º(äÑۮ⩠û¡à÷).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • free radical formation,oxygen toxicity
    ÀÚÀ¯ ·¡µðÄ® Çü¼º, »ê¼Òµ¶¼º(ß«áÈÔ¸àõ)
  • free radical formation
    ÀÚÀ¯ ·¡µðÄ® Çü¼º
  • free radical formation,irradation injury
    ÀÚÀ¯ ·¡µðÄ® Çü¼º, ¹æ»ç¼± ¼Õ»ó(Û¯ÞÒàÊ áßß¿)
  • free radical formation,lipid peroxidation
    ÀÚÀ¯ ·¡µðÄ® Çü¼º, ÁöÁú °ú»êÈ­(ò·òõ Φ߫ûù)
  • free radical formation,oxygen derived
    ÀÚÀ¯ ·¡µðÄ® Çü¼º, »ê¼Ò ±â¿ø¼º(ß«áÈ ÑÃê¹àõ)
  • free radical formation,propagation
    ÀÚÀ¯ ·¡µðÄ® Çü¼º, ÀüÆÄ
  • free radical formation,redox reactions
    ÀÚÀ¯ ·¡µðÄ® Çü¼º, »êȭȯ¿ø¹ÝÀÀ(ß«ûùü½êªÚãëë)
  • free radical formation,superoxide dismutase
    ÀÚÀ¯ ·¡µðÄ® Çü¼º, °ú»êÈ­ dismutase
  • aging,free radical theory
    À¯¸®±â ¼³(ë´×îÐñàã)
  • free radical
    ÀÚÀ¯¶óµðÄ®, À¯¸®±â, ÀÚÀ¯±â.
  • free radical
    ÀÚÀ¯(í»ë¦) ·¡µðÄ®
  • free radical quencher
    À¯¸®±â<ÀÚÀ¯±â>Á¦°Å¹°Áú.
  • free radical quencher
    À¯¸®±â <ÀÚÀ¯±â>Á¦°Å¹°Áú.
  • oxidative free radical
    »êÈ­ ÀÚÀ¯±â
  • oxygen free radical
    »ê¼Ò ÀÚÀ¯±â
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Dendrite formation
    °¡Áöµ¹±âÇü¼º
    [¿¾ ¿ë¾î] ¼ö»óµ¹±âÇü¼º
  • Reticular formation
    ±×¹°Ã¼
    [¿¾ ¿ë¾î] ¸Á»óü
  • Nuclei of reticular formation of brain stem
    ³úÁÙ±â±×¹°ÇÙ
    [¿¾ ¿ë¾î] ³ú°£¸Á»óüÇÙ
  • Process formation
    µ¹±âÇü¼º
    [¿¾ ¿ë¾î] µ¹±âÇü¼º
  • Rouleaux formation
    ÀûÇ÷±¸¿°ÁÖ
    [¿¾ ¿ë¾î] ÀûÇ÷±¸±ºÁý
  • Articulations of free lower limb
    ÀÚÀ¯´Ù¸®°üÀý
    [¿¾ ¿ë¾î] ÀÚÀ¯ÇÏÁö°üÀý
  • Free margin
    ÀÚÀ¯¸ð¼­¸®
    [¿¾ ¿ë¾î] ÀÚÀ¯¿¬
  • Free part
    ÀÚÀ¯ºÎºÐ
    [¿¾ ¿ë¾î] À¯¸®ºÎ
  • Free nerve terminal
    ÀÚÀ¯½Å°æÁ¾¸»
    [¿¾ ¿ë¾î] ÀÚÀ¯½Å°æÁ¾¸»
  • Bones of free lower limb
    ÀÚÀ¯´Ù¸®»À
    [¿¾ ¿ë¾î] ÀÚÀ¯ÇÏÁö°ñ
  • Free villus
    ÀÚÀ¯À¶¸ð
    [¿¾ ¿ë¾î] À¯¸®À¶¸ð
  • Bones of free upper limb
    ÀÚÀ¯ÆÈ»À
    [¿¾ ¿ë¾î] ÀÚÀ¯»óÁö°ñ
  • Free border
    ÀÚÀ¯¸ð¼­¸®
    [¿¾ ¿ë¾î] ÀÚÀ¯¿¬
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • radical cure
    ±ÙÄ¡¿ä¹ý
  • free-living ameba
    ÀÚÀ¯»ýȰ¾Æ¸Þ¹Ù
  • free-living cycle
    ÀÚÀ¯»ýȰȯ
  • free-living form
    ÀÚÀ¯»ýȰÇü
  • free-living generation
    ÀÚÀ¯»ýȰ¼¼´ë
  • free living species
    ÀÚÀ¯»ýȰÁ¾
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • free radical
    ÀÚÀ¯(í»ë¦) ·¡µðÄ®
  • chronic toxicity test
    ¸¸¼º µ¶¼º½ÃÇè(Ø·àõÔ¸àõãËúÐ)
  • selective toxicity
    ¼±ÅÃÀûµ¶¼º(àÔ÷ÉîÜÔ¸àõ)
  • toxicity
    µ¶¼º(Ô¸àõ)
  • toxicity index
    µ¶¼ºÁö¼ö (Ô¸àõò¦â¦)
  • antibody formation
    Ç×ü Çü¼º(ù÷ô÷û¡à÷)
  • Bjerrum formation function
    º£¿¡·ë Çü¼ºÇÔ¼ö(û¡à÷ùÞâ¦)
  • cointegrate formation
    "°øÅëÇÕÇü¼º(Íì÷×ùêû¡à÷), (ÔÒ) replicon fusion"
  • formation constant
    Çü¼º »ó¼ö(û¡à÷ßÈâ¦)
  • formation reaction
    Çü¼º ¹ÝÀÀ(û¡à÷Úãëë)
  • theory of antibody formation
    Ç×üÇü¼º ÀÌ·Ð (ù÷ô÷û¡à÷×âÖå)
  • carbon radical
    ź¼Ò(÷©áÈ) ¶óµðÄ®
  • hydroperoxyl radical
    °ú»êÈ­ ¼ö¼Ò(Φ߫ûùâ©áÈ) ·¡µðÄ®
  • radical
    ¶óµðÄ®
  • radical amino acid replacement
    ¶óµðÄ® ¾Æ¹Ì³ë»ê ġȯ(öÇüµ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • oxidative free radical
    »êÈ­ÀÚÀ¯±â
  • oxygen free radical
    »ê¼ÒÀÚÀ¯±â
  • toxicity
    µ¶¼º, µ¶·Â
  • new bone formation
    ½Å°ñÇü¼º
  • rosette formation
    ·ÎÁ¦Æ®Çü¼º
  • thrombus formation
    Ç÷ÀüÇü¼º
  • whorl formation
    ¼Ò¿ëµ¹ÀÌ ¸ð¾ç
  • modified radical mastectomy
    º¯Çü±ÙÄ¡À¯¹æÀýÁ¦¼ú
  • radical
    ±ÙÄ¡(Àû), ±â±Ù
  • radical
    ±ÙÄ¡Àû, ±â
  • radical excision
    ±ÙÄ¡ÀýÁ¦
  • radical lymph node dissection
    ±ÙÄ¡Àû¸²ÇÁÀý¹Ú¸®, ¸²ÇÁÀý°ûû¼ö¼ú
  • radical mastectomy
    ±ÙÄ¡ÀûÀ¯¹æÀýÁ¦¼ú
  • radical mastoidectomy
    À¯µ¹±ÙÄ¡ÀýÁ¦¼ú
  • radical neck dissection
    °æºÎ°ûû¼ö¼ú, °æºÎ±ÙÄ¡¼ö¼ú
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
MRF Markov random field; medical record file; melanocyte-[stimulating hormone]-releasing factor; mesence...
RF radial fiber; radio frequency; receptive field; regurgitant fraction; Reitland-Franklin [unit]; rela...
SF Sabin-Feldman [test]; safety factor; salt-free; scarlet fever; screen film; seminal fluid; serosal f...
AFR aqueous flare response; ascorbic free radical
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AFR Ascorbate free radical
FR Free radical
OFR Oxygen free radical
FRO free radical oxidation
*OH of hydroxyl free radical
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • aging,free radical theory
    À¯¸®±â¼³
  • free radical quencher
    À¯¸®±â Á¦°Å ¹°Áú
  • acute toxicity
    ±Þ¼º Áßµ¶, ±Þ¼º µ¶¼º
  • anesthetic toxicity
    ¸¶ÃëÁ¦ µ¶¼º
  • chronic toxicity
    ¸¸¼º µ¶¼º
  • mercury toxicity
    ¼öÀº µ¶¼º
  • oxygen toxicity
    »ê¼Ò µ¶¼º
  • selective toxicity
    ¼±Åà µ¶¼º
    ¼÷ÁÖ ¼¼Æ÷¿Í ±â»ý ¼¼Æ÷¿¡ ÀÛ¿ëÇÏ´Â µ¶¼ºÀÇ »óÀÌ.
  • toxicity
    µ¶¼º, µ¶·Â
    À¯ÇØÇÑ ¼ºÁú. ƯÈ÷ À¯ÇØÇÑ ¹Ì»ý¹°À̳ª À¯µ¶ ¹°ÁúÀÇ µ¶¼ºÀÇ Á¤µµ.
  • acid radical
    »ê±â
    À¯±â, ¹«±âÀÇ °¢Á¾ »êÀÇ ºÐÀڷκÎÅÍ ¼ö¼Ò ÀÌ¿ÂÀ¸·Î¼­ ÀÌ¿ÂÈ­ ÇÒ ¼ö ÀÖ´Â ¼ö¼Ò ¿øÀÚ¸¦ ÇÑ °³ ÀÌ»ó ¶¼¾î ³½ ³ª¸ÓÁö ¿øÀÚ ¶Ç´Â ¿øÀÚ´Ü.
  • complex radical
    ¹æ»ç Âø±â
  • cystoprostatectomy, radical
    ±ÙÄ¡Àû ¹æ±¤ Àü¸³¼± ÀûÃâ¼ú
  • modified radical mastoidectomy
    º¸Á¸Àû ÁßÀÌ ±ÙÄ¡¼ú
  • radical
    ±ÙÄ¡Àû, ±â±Ù, ±ÙÄ¡ÀûÀÇ, ±Ùº»ÀÎ, ±â, ¶óµðÄ®, Àܱâ
    1. º´Àû °úÁ¤ÀÇ ±Ù¿ø ¶Ç´Â ¿øÀÎÀÇ ±ÙÀý¿¡ ´ëÇÏ¿© ¸»ÇÑ´Ù. 2. È­ÇÐ ¹ÝÀÀ¿¡ ÀÖ¾î º¯È­ÇÏÁö ¾Ê°í ±×´ë·Î À̵¿ÇÏ´Â 1±ºÀÇ ¿øÀÚÀÌ¸ç ºÐÀÚ¸¦ ±¸¼ºÇÏ´Â ±âº»ÀûÀÎ ¿ä¼Ò°¡ µÈ´Ù.
  • radical cure
    ±ÙÄ¡ ¿ä¹ý
    1. ¿ÏÀüÇÏ°í ¿µ±¸ÀûÀÎ Ä¡·á. 2. ´ë±Ô¸ðÀÇ ¿Ü°ú¼ö¼úÀ» ¼ö¹ÝÇÏ´Â Ä¡·á.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
radical, free In biochemistry, it is a group of atoms bonded together into an entity that is extremely reactive and shortlived. (a free radical is not a political extremist on parole.)
(12 Dec 1998)
free radical A chemically active atom or molecular fragment containing a chemical charge due to an excess or deficient number of electrons. Radicals seek to receive or release electrons in order to achieve a more stable configuration, a process that can damage the large molecules within cells.
See: Oxidation.
(09 Oct 1997)
free radical reductase <enzyme> Catalyses conversion of carbon-centreed lipid radicals into an inactive species by utilizing vitamin e at one end and glutathione at the other
Registry number: EC 1.8.4.-
(26 Jun 1999)
free radical scavengers Substances that influence the course of a chemical reaction by ready combination with free radicals. Among other effects, this combining activity protects pancreatic islets against damage by cytokines and prevents myocardial and pulmonary perfusion injuries.
(12 Dec 1998)
acute toxicity <pharmacology> Illness resulting from a single dose or exposure to a toxic substance.
Compare: chronic toxicity.
(06 May 1997)
chronic toxicity <pharmacology> Illness caused by repeated or long-term exposure to low doses of a toxic substance.
Compare: acute toxicity.
(09 Oct 1997)
digitalis toxicity A result of the over-accumulation of digitalis glycosides in the body. Kidney insufficiency can be a contributing factor.
Symptoms include nausea, vomiting, visual changes, blurred vision, anorexia and palpitations. Treatment is emergent as life-threatening cardiac arrhythmias are possible with higher blood levels.
(27 Sep 1997)
digoxin toxicity A result of the over-accumulation of digitalis glycosides in the body. Kidney insufficiency can be a contributing factor.
Symptoms include nausea, vomiting, visual changes, blurred vision, anorexia and palpitations. Treatment is emergent as life-threatening cardiac arrhythmias are possible with higher blood levels.
(27 Sep 1997)
drug toxicity The systemic effects of a drug that are related to the overall level of the medication in the bloodstream. Drug toxicity may occur with overdosage of a medication, accumulation of the drug in the body over time or the inability of the patients body to eliminate the drug.
(27 Sep 1997)
oxygen toxicity A body disturbance resulting from breathing high partial pressures of oxygen; characterised by visual and hearing abnormalities, unusual fatigue while breathing, muscular twitching, anxiety, confusion, incoordination, and convulsions; although the mechanism for development of the condition is obscure, a disruption of enzymatic activity is likely, perhaps as a result of free radical formation.
Synonym: oxygen poisoning.
(05 Mar 2000)
toxicity The quality of being poisonous, especially the degree of virulence of a toxic microbe or of a poison.
(18 Nov 1997)
toxicity test <investigation> Controlled laboratory test to determine the toxicity of a chemical to an organism in terms of specific chemical concentrations.
An acute toxicity test establishes the concentration required to kill a predetermined proportion of test organisms within a relatively short period of time, typically 4 days or less. A chronic toxicity test reveals the effects of a sublethal concentration applied throughout all or part of the life cycle.
(12 Jan 1998)
toxicity tests Tests that determine the toxicity of a substance. These include tests of clinical drugs, foods, environmental pollutants, etc.
(12 Dec 1998)
ep toxicity A test defined by the federal Environmental Protection Agency to check a substance for the presence of arsenic, barium, cadmium, chromium, lead, mercury, selenium, or silver. 40 CFR 261.24 defines the concentrations constituting hazardous waste and the test procedure.
(05 Dec 1998)
Abbe theory of image formation <optics, physics> Abbe's theory is based on the fact that a non-self-luminous particle, which is illuminated by an extraneous source, gives rise to diffracted light rays, in addition to the dioptric pencil.
He stated that to form a good microscopical image as many of the diffracted rays as possible should be intercepted by the objective. With closely ruled lines, his theory is easily demonstrated by observing the back lens of the objective, for here the diffracted rays can be observed directly if the aperture diaphragm is closed. It can be shown that, when the illumination is arranged to exclude the diffracted images, resolution is lost.
(11 Mar 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • free radical
    À¯¸®±â
  • toxicity
    (À¯)µ¶¼º
  • radical
    ±Ùº»ÀÇ
  • hydroxyl radical
    ¼ö»ê±â
  • radical
    ±Ùº»ÀûÀÎ;±âÃÊÀûÀÎ;(°³Çõ.Ä¡·áµîÀÌ)¹ßº»ÀûÀÎ;öÀúÇÑ;(»ç¶÷.»ç»óµîÀÌ)°ú°ÝÇÑ;±ÞÁøÀûÀÎ(extreme);Çõ¸íÀûÀÎ(revolutionary);±ÙÀÇ;ºÎÁø±ÙÀÇ;¾î±ÙÀÇ;±Ù»ýÀÇ;±âÀÇ;±ÙÀ½ÀÇ;°ú°Ý·ÐÀÚ;±ÞÁøºÐÀÚ;±ÞÁø´ç¿ø;±ÞÁøÆÄ;¾î±Ù;(ÇÑÀÚÀÇ)ºÎ¼ö;(º¯.Æí.¹æ.°ü.°¢);±â(root);±ÙÀ½;ºÎÁø±Ù¼ö;±ÙÈ£;~ism
  • radical chic
    (»ç±³°èÀÇ)°ú°ÝÆÄ¸¦ ÁÁ¾ÆÇϱâ
  • radical left
    =NEW LEFT
  • radical right
    ±ÞÁø¿ìÀÍ;±Ø¿ì
  • I formation
    µÎ¼¼¸íÀÇ backÀÌ quarterback ¹Ù·Î µÚ¿¡ IÀÚ ²Ã·Î ¼­´Â °ø°Ý´ëÇü
  • back formation
    ¿ª¼º;¿ª¼º¾î
  • diluvial formation
    È«ÀûÃþ
  • flight formation
    ºñÇà ´ëÇü(Æí´ë)
  • formation
    Çü¼º;Á¶Á÷;±¸Á¶;´ëÇü;Æí´ë. formational a.
  • re-formation
    ÀçÇü¼º;°³Á¶;°³Àå;À籸¼º;ÀçÆí¼º
  • reaction formation
    ¹Ýµ¿ Çü¼º(»çȸÀû.µµ´öÀûÀ¸·Î ÁÁÁö ¾ÊÀº ¿å±¸³ª ¿ø¸ÁÀ» ¾ïÁ¦Çϱâ À§ÇÏ¿© ÀÌ ¿å±¸¿Í´Â ¹Ý´ë ¹æÇâÀÇ µ¶´ÜÀû ÇൿÀ» ÃëÇÏ´Â ¹«ÀǽÄÀû ÇàÀ§)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á